I hope that this glimpse of Ms. Peyton demonstrates what an extraordinary RN she is. She heals her patients with direct care, improvement in policy and a commitment to safety.
An Extraordinary Healer essay honoring VICTORIA FENSTERMAKER, RN, AAS [ROSWELL PARK CANCER INSTITUTE, BUFFALO, NEW YORK]
Hope S. Rugo discusses managing sexual dysfunction from ovarian suppression treatment for breast cancer.
Yvonne Saenger, director of melanoma and immunotherapy at Columbia University Medical Center, discusses the side effects patients should look out for when they are on immunotherapy, and how to determine if they are experiencing normal therapy-induced fatigue or if they are suffering from a hormone reaction and should go see their medical team.
A diagnosis of Waldenstrom's macroglobulinemia can be scary, but it doesn't need to be faced alone.
For Gail Powell, helping others through her cervical cancer treatment was, in turn, one of the biggest things she did to help herself.
YONDELIS (trabectedin) and HALAVEN (eribulin) are the first chemotherapies originally derived from marine life, although they are now synthetically made. Both drugs are approved for the treatment of liposarcoma, and Yondelis also for the treatment of leiomyosarcoma.
After one woman’s father received a terminal stomach cancer diagnosis, she turned to Debbie’s Dream Foundation: Curing Stomach Cancer for information and guidance.
A survivor's story of overcoming fear of myeloma recurrence.
Deciding between complex cancer treatment options can be overwhelming, and each choice has pros and cons, but following a few tips of advice may ease the decision-making process
Komen vows to drive breakthroughs for the most-deadly breast cancers and educate those who believe breast cancers are easily treated or always curable.
I work with cancer patients every day at Memorial Sloan Kettering Cancer Center, and I love what I do. But, this is not my story; this is the story of a nurse who stood next to me during a terrible storm in my life.
Undertaking the cancer journey is a daunting task with its own challenges and tough questions to face, but that doesn't mean you have to do it alone.
Susan Leigh’s story about how she turned her cancer experience into an advocacy action plan.
In an interview with CURE®, Dr. Jorge Gomez discussed how recent developments in the assessment of biomarkers within the small cell lung cancer and non-small cell lung cancer space have led to approvals of new and expanded therapies.
These expert tips can help ensure that treatment plans are followed.
An Extraordinary Healer essay honoring JANET SCHADEE, M.S.N. [SAN ANTONIO MILITARY MEDICAL CENTER, SAN ANTONIO, TEXAS]
After being diagnosed with metastatic breast cancer, nurse Stephanie Walker was thrown into a world of isolation and new depths of depression she “never knew even existed”. Here, she details how working with a therapist and communicating with her family and friends helped her find her way out of the darkness.
Minimizing and preventing late effects of stem cell transplantation.
Know your rights and make a plan to help ensure a smooth transition back into the workforce.
This research was presented at the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of over 30,000 oncology professionals in Chicago.
Patricia J. Goldsmith, CEO of CancerCare, discusses the importance of coordinating between health care professionals as a patient moves into survivorship and converts to treating cancer as a chronic illness.
After treatment, this survivor was terrified of everyone and everything until her very wise doctor said, “I did not put you through all this for you to put yourself in a bubble – go live your life.” And she has… for 16 years and counting.
While scientists have a limited understanding of how brain metastases genetically evolve from their primary tumor, research presented at the Society for Neuro-Oncology’s Annual Meeting may have identified a connection between genetic mutations and treatment options that could offer patients improved outcomes.